Antiepileptic drug utilization in Taiwan: Analysis of prescription using National Health Insurance database

Epilepsy Research

Volumn 84, Issue 1, 2009, Pages 21-27

  Hsieh, Liang Po ^a   Huang, Chin Yin ^b  

^a CHENG CHING GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Antiepileptic drugs; Epilepsy; Health insurance database; Prescribed daily dose

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; DRUG DOSE REDUCTION; DRUG USE; DRUG UTILIZATION; EPILEPSY; HUMAN; INFORMATION RETRIEVAL; MEDICAL RECORD; MONOTHERAPY; NATIONAL HEALTH INSURANCE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REFERENCE DATABASE; TAIWAN; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EPILEPSY; FEMALE; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TAIWAN; YOUNG ADULT;

EID: 60949096315     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.11.018     Document Type: Article

References (24)

1. Albani F., Grassi B., Ferrara R., Turrini R., Baruzzi A., and Grp P.S. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure Eur. J. Epilep. 13 (2004) 254-263
2. Chadwick D. Epilepsy. J. Neurol. Neurosurg. Psychiatr. 57 (1994) 264-277
3. Chen T.J., Chou L.F., and Hwang S.J. Patterns of ambulatory care utilization in Taiwan. BMC Health Serv. Res. 6 (2006) 54
4. Cheng T.M. Taiwan's new national health insurance program: genesis and experience so far. Health Affairs 22 (2003) 61-76
5. Chien I.C., Chou Y.J., Lin C.H., Bih S.H., Chou P., and Chang H.J. Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996-2001. Psychiatr. Clin. Neurosci. 58 (2004) 611-618
6. Cockerell O.C., Johnson A.L., Sander J., Hart Y.M., and Shorvon S.D. Remission of epilepsy-results from the national general-practice study of epilepsy. Lancet 346 (1995) 140-144
7. Deckers C.L.P. Overtreatment in adults with epilepsy. Epilepsy Res. 52 (2002) 43-52
8. Ferrendelli J.A. Pharmacology of antiepileptic drug polypharmacy. Epilepsia 40 (1999) S81-S83
9. Giuliani G., Terziani S., Senigaglia A.R., Luccioni G., Foschi N., and Maffei C. Epilepsy in an Italian Community as assessed by a survey for prescriptions of antiepileptic drugs-epidemiology and patterns of care. Acta Neurol. Scand. 85 (1992) 23-31
10. Houtkooper M.A., Lammertsma A., Meyer J.W.A., Goedhart D.M., Meinardi H., Vanoorschot C., Blom G.F., Hoppener R., and Hulsman J. Oxcarbazepine (Gp-47.680)-a possible alternative to carbamazepine. Epilepsia 28 (1987) 693-698
11. Hsieh L.-P., and Huang C.Y. Prevalence of treated epilepsy in western medicine among the adult population in Taiwan: a study conducted using antiepileptic drug prescription data. Epilepsy Res. 80 (2008) 114-118
12. Koristkova B., Bergman U., Grundmann M., Brozmanova H., and Sjovist F. Therapeutic monitoring of antiepileptic drugs: a comparison between a Czech and a Swedish university hospital. Ther. Drug Monit. 28 (2006) 594-598
13. Koristkova B., Grundmann M., and Brozmanova H. Differences between prescribed daily doses and defined daily doses of antiepileptics-therapeutic drug monitoring as a marker of the quality of the treatment. Int. J. Clin. Pharmacol. Therap. 44 (2006) 438-442
14. Koristkova B., Sjoqvist F., Grundmann M., and Bergman U. The use of TDM data to assess the validity of defined daily doses of antiepileptics: a comparison between a Czech and Swedish University Hospital. Ther. Drug Monit. 28 (2006) 589-593
15. Kwan P., and Brodie M.J. Effectiveness of first antiepileptic drug. Epilepsia 42 (2001) 1255-1260
16. Lammers M.W., Hekster Y.A., Keyser A., Meinardi H., Renier W.O., and Herings R.M.C. Use of antiepileptic drugs in a community-dwelling Dutch population. Neurology 46 (1996) 62-67
17. Lhatoo S.D., Sander J., and Shorvon S.D. The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11-14 years. J. Neurol. Neurosurg. Psychiat. 71 (2001) 632-637
18. Mattson R.H., Cramer J.A., Collins J.F., Smith D.B., Delgadoescueta A.V., Browne T.R., Williamson P.D., Treiman D.M., McNamara J.O., McCutchen C.B., Homan R.W., Crill W.E., Lubozynski M.F., Rosenthal N.P., and Mayersdorf A. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic clonic seizures. N. Engl. J. Med. 313 (1985) 145-151
19. Oun A., Haldre S., and Magi M. Use of antiepileptic drugs in Estonia: an epidemiologic study of adult epilepsy. Eur. J. Neurol. 13 (2006) 465-470
20. Patsalos P.N., and Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2 (2003) 347-356
21. Reinikainen K.J., Keranen T., Halonen T., Komulainen H., and Riekkinen P.J. Comparison of oxcarbazepine and carbamazepine-a double-blind-study. Epilepsy Res. 1 (1987) 284-289
22. Rochat P., Hallas J., Gaist D., and Friis M.L. Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol. Scand. 104 (2001) 6-11
23. Sander J. Some aspects of prognosis in the epilepsies-a review. Epilepsia 34 (1993) 1007-1016
24. Shackleton D.P., Westendorp R.G.J., Trenite D., deBoer A., and Herings R.M.C. Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J. Clin. Epidemiol. 50 (1997) 1061-1068